Grant: Project Grant
McMaster University
$244,800.00
Intravascular Ultrasound for Peripheral Artery Disease Revascularization: The CLARITY Randomized Controlled Trial
EF 2024-25
Résumé
Peripheral artery disease (PAD) is characterized by blockages in the arteries frequently located in the lower limbs. In severe cases, lack of blood flow can lead to pain, ulceration, and limb amputation if not promptly restored. Balloons and stents can restore blood flow by using X-ray images of the arteries (angiography) to identify these blockages. However, angiography is not precise, often leading to using balloons and stents that are not the best size for reopening blockages. This may lead to a re-narrowing of the arteries requiring repeat interventions and potential amputation.
Intravascular ultrasound (IVUS) is a device that is inserted inside the arteries to create high-resolution images of the blood vessels. This facilitates a better selection of the equipment to fix blockages than angiography. In the arteries of the heart, IVUS use has been shown to reduce the re-narrowing of stents and improve patient outcomes. Despite this knowledge, there has been limited investigation into the benefit of using this technology in treating blocked arteries in the legs.
The IntravasCular ULtrAsound foR perIpheral arTerY Disease: The CLARITY randomized controlled trial will recruit patients with PAD who are already scheduled to undergo angiography to restore blood flow. Study participants will then be assigned randomly to have their procedure done with only angiography or angiography and IVUS together. We aim to evaluate whether IVUS can be used consistently and reliably in patients with PAD. If possible, we will determine if IVUS can reduce adverse events such as amputation, re-intervention or re-narrowing of the arteries.
The Population Health Research Institute will be the coordination centre of this multidisciplinary collaborative study involving vascular surgeons, interventional radiologists and interventional cardiologists. Our findings may lead to major improvements in how PAD is treated and, most importantly, improve the health and wellness of patients.
Programme
Project Grant
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
509518
Name
Jolly Sanjit S
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Randomized Controlled Trials
Projecttitle
Intravascular Ultrasound for Peripheral Artery Disease Revascularization: The CLARITY Randomized Controlled Trial
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$244,800
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Intravascular Imaging; Major Adverse Limb Events; Peripheral Artery Disease; Randomized Controlled Trial
Abstract
Peripheral artery disease (PAD) is characterized by blockages in the arteries frequently located in the lower limbs. In severe cases, lack of blood flow can lead to pain, ulceration, and limb amputation if not promptly restored. Balloons and stents can restore blood flow by using X-ray images of the arteries (angiography) to identify these blockages. However, angiography is not precise, often leading to using balloons and stents that are not the best size for reopening blockages. This may lead to a re-narrowing of the arteries requiring repeat interventions and potential amputation.
Intravascular ultrasound (IVUS) is a device that is inserted inside the arteries to create high-resolution images of the blood vessels. This facilitates a better selection of the equipment to fix blockages than angiography. In the arteries of the heart, IVUS use has been shown to reduce the re-narrowing of stents and improve patient outcomes. Despite this knowledge, there has been limited investigation into the benefit of using this technology in treating blocked arteries in the legs.
The IntravasCular ULtrAsound foR perIpheral arTerY Disease: The CLARITY randomized controlled trial will recruit patients with PAD who are already scheduled to undergo angiography to restore blood flow. Study participants will then be assigned randomly to have their procedure done with only angiography or angiography and IVUS together. We aim to evaluate whether IVUS can be used consistently and reliably in patients with PAD. If possible, we will determine if IVUS can reduce adverse events such as amputation, re-intervention or re-narrowing of the arteries.
The Population Health Research Institute will be the coordination centre of this multidisciplinary collaborative study involving vascular surgeons, interventional radiologists and interventional cardiologists. Our findings may lead to major improvements in how PAD is treated and, most importantly, improve the health and wellness of patients.
Competitiondate
202409
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Jolly, Sanjit S; d'Entremont, Marc-André; Harlock, John; Secemsky, Eric A
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $244,800~ $0~